EXCEL and NOBLE: stents or surgery for left main stem stenosis?

EuroIntervention 2017;13:e604-e608 published online e-edition August 2017. DOI: 10.4244/EIJV13I5A94

Fabio Mangiacapra
Fabio Mangiacapra1*, MD, PhD; Michael Maeng2, MD, PhD; Guillaume Cayla3, MD, PhD; Alexandra Lansky4, MD; Pascal Meier5, MD; Philippe Kolh6, MD, PhD
1. Campus Bio-Medico University of Rome, Rome, Italy; 2. Aarhus University Hospital, Aarhus, Denmark; 3. University Hospital of Nîmes, University of Montpellier, Nîmes, France; 4. Yale University School of Medicine, New Haven, CT, USA, and St Bartholomew’

Introduction to the session: the trial headlines

The aim of the article is to capture the session at EuroPCR 2017 covering the EXCEL and NOBLE trials, communicate the analysis of the trialists, and report the views expressed in the interactive discussion. This article does not constitute an independent review of the topic by the authors. The session was dedicated to the critical review and analysis of two recent major randomised controlled trials (RCT) comparing percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) surgery for the treatment of left main (LM) disease, namely the Evaluation of XIENCE versus ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Coronary interventionsLeft main and multivessel diseaseBypass surgery
Read next article
Will PIONEER AF-PCI change my practice?

Latest news